Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05723601 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Jan 2026 to Jan 2027
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 24 to confirmed 21
    • Site details revised
    v10
  2. Primary and study completion dates: Jan 2025 to Jan 2026v9
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2024 to Jan 12, 2024
    • Site details revised
    v8
  4. Start date: Nov 2023 to Jan 2024
    • Primary and study completion dates: Nov 2024 to Jan 2025
    v7
  5. Start date: Sep 2023 to Nov 2023
    • Primary and study completion dates: Sep 2024 to Nov 2024
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Start date: Jul 2023 to Sep 2023
    • Primary completion date: Jun 2024 to Sep 2024
    • Study completion date: Jun 2025 to Sep 2024
    v5
  2. Start date: May 2023 to Jul 2023v4
  3. Start date: Mar 2023 to May 2023v3
  4. Start date: Feb 2023 to Mar 2023v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Vaginally applied estrogen has been shown to decrease the incidence of Recurrent Urinary Tract Infection (rUTI) in post-menopausal women. However, prior studies have shown the compliance rate for topical estrogen cream is low. The vaginal estradiol tablet has been shown to be preferred by patients being treated for genitourinary syndrome of menopause and has improved compliance. There are no studies looking at the preference of post-menopausal women with rUTI for vaginal estradiol tablet as an alternative to vaginal estradiol cream.
Trial Details
NCT Number NCT05723601
Lead Sponsor Wake Forest University Health Sciences
Conditions
(from sponsor)		 Recurrent Urinary Tract Infection
Related terms Urinary Tract Infections
Enrollment 21 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov